Interventional X-ray Equipment Markets Plummeted in 2020 Due to COVID

Bhvita Jani headshot
Bhvita Jani
Published: February 24, 2021 In The News

19th January 2021 – Written by Bhvita Jani – Featured on Diagnostic and Interventional Cardiology – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources for COVID-19 patients during the start of the pandemic, cardiovascular procedures were severely impacted. The increased costs of caring for COVID patients, personal protective equipment (PPE) and the loss of elective procedure revenue caused a massive financial burden on healthcare providers. This is expected to result in reduced capital expenditure budgets for imaging equipment, including interventional angiography imaging systems and surgical mobile C-arm X-ray systems.

Read full article here

You may also like
Insight
21 Jun 2023: Medical Imaging
Interventional X-ray & Mobile C-arm Equipment Markets collectively exceed $4 billion in 2022
Signify Research’s recent report “Interventional and Surgical X-ray – World – 2023” presents market dynamics, estimates, forecasts, competitive analysis and major drivers for the Interventional and Surgical X-ray market. Products included in this report are image intensifier mobile C-arm, 2D mobile C-arm, 3D mobile C-arm and O-arm, Hybrid operating rooms, General vascular angiography, Oncology / Body, Neurology, Interventional gastro, General coronary, Structural heart lab and Electrophysiology.
Arrow Right
Insight
20 Jul 2023: Medical Imaging
Fixed Digital Radiography Systems Market Set to Reach $1.3 Billion in 2023
2022 was somewhat challenging for vendors of fixed digital radiography (DR) systems, with market expansion impeded by inflationary pressure, stretched healthcare budgets and increased average selling prices.
Arrow Right
Insight
11 Mar 2024: Medical Imaging
The Medical FPD Market Reaches 78,000 units
The medical FPD market, totalling just under 78,000 units in 2022, witnessed a slight retraction in both units and revenue. The most significant decline was seen in mobile general radiography, which was attributed to a surplus during the pandemic. A decline was also seen for mammography due to a shortage of semi-conductors, inflation hikes, and a market correction following elevated investment in breast imaging systems in 2021 as budgets returned post-COVID. However, the resurgence of elective procedures, coupled with pent-up demand, contributed to the positive uptake of mobile C-arm technology.
Arrow Right